Overview

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Status:
NOT_YET_RECRUITING
Trial end date:
2029-11-05
Target enrollment:
Participant gender:
Summary
Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in adult participants with cachexia and metastatic pancreatic ductal adenocardinoma.
Phase:
PHASE2
Details
Lead Sponsor:
Pfizer